Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Cardiology

How Does Friedreich Ataxia Affect Heart Function and Rhythm?

At a Glance

Friedreich ataxia can affect the heart by disrupting energy production in heart cells, leading to thickened heart muscle, irregular rhythms, and sometimes weaker pumping. Regular heart electrical tests and ultrasounds can detect changes before symptoms appear.

Friedreich ataxia (FA) affects the heart because the genetic mutation reduces the production of frataxin, a protein crucial for creating energy within cells [1]. The heart muscle requires a massive amount of energy to pump continuously. Without enough frataxin, the energy factories in the heart cells (the mitochondria) cannot function properly, and iron handling inside the cells becomes abnormal (this is different from having too much iron in your bloodstream) [1][2]. These cellular changes stress the heart, leading to a condition known as a mitochondrial cardiomyopathy [2]. Over time, this can lead to thickened heart walls, irregular heartbeats (arrhythmias), or in some patients, a weakened heart muscle (heart failure) [3][4].

Cardiac involvement varies widely from person to person; some people have no obvious symptoms for years, while others require active treatment [4]. Because heart complications are a major driver of symptoms and mortality in Friedreich ataxia, proactive monitoring and a cardiologist on your care team are essential [5][6].

What is Hypertrophic Cardiomyopathy in FA?

Hypertrophic cardiomyopathy means that the walls of the heart muscle—typically the left ventricle, which is the main pumping chamber—have become abnormally thick [7].

In the general population, hypertrophic cardiomyopathy is usually caused by genetic mutations affecting the structural, contractile proteins of the heart muscle (sarcomeres). However, in Friedreich ataxia, the thickening is a different process driven by mitochondrial dysfunction, altered iron handling, and cellular stress attempting to meet the heart’s intense energy demands [2].

When the heart muscle thickens in FA, it affects how the heart works:

  • Impaired Filling (Diastolic Dysfunction): The thick muscle becomes rigid, making it harder for the heart to relax and fill with blood between beats [8].
  • Preserved Pumping (Systolic Function): Early on, despite being thick and stiff, the heart can usually still pump efficiently. The percentage of blood pumped out with each beat (ejection fraction) often remains normal or even high [8][4].

Because the heart can still pump well early on, many people may not notice obvious cardiac symptoms during this stage, making routine testing important to catch silent changes.

How Cardiac Issues Can Progress

The progression of heart issues in Friedreich ataxia is variable. Some people maintain stable heart function for decades, while others experience changes over time [4].

  • Fibrosis: Heart muscle cells can become injured, leaving behind scar tissue in a process called myocardial fibrosis [9]. This scarring can further stiffen the heart and disrupt its electrical signals [7].
  • Arrhythmias: Scarring and structural changes can cause irregular heartbeats, known as arrhythmias [7][4]. Patients may develop atrial fibrillation (an irregular, often rapid heartbeat in the upper chambers) or, less commonly, ventricular arrhythmias (abnormal rhythms in the lower chambers) [10].
  • Heart Failure: In some patients, the thickened heart muscle may eventually thin out, dilate (enlarge), and weaken [3]. When the left ventricle loses its ability to pump blood effectively, the ejection fraction declines [4][6]. This state is known as chronic heart failure, which can cause fatigue, shortness of breath, and fluid buildup (swelling in the legs) [3].

Standard of Care and Monitoring

Because managing cardiac health is a central part of Friedreich ataxia care, a cardiologist should evaluate you regularly [6].

Routine Foundation Tests

These tests are often done annually, though the schedule depends on your age, symptoms, and prior results:

  • Electrocardiogram (ECG): A brief test checking the electrical activity of the heart to look for abnormal rhythms [6].
  • Echocardiogram: An ultrasound of the heart that measures wall thickness, chamber size, and pumping function (ejection fraction) [6].

Additional Specialized Testing

Depending on your symptoms or ECG findings, your cardiologist might order [11]:

  • Holter Monitor: A wearable device that records the heart’s rhythm for 24 hours or longer, used to catch intermittent arrhythmias if you experience palpitations or dizziness [12][11].
  • Cardiac MRI: An imaging test providing detailed pictures of the heart structure to look for scarring (fibrosis) when an echocardiogram doesn’t provide enough information [7][11].
  • Blood Biomarkers: Tests measuring high-sensitivity troponin (which reflects heart muscle injury) and NT-proBNP (which reflects stress or stretching of the heart wall) can sometimes help identify patients who need closer surveillance, though their routine use in FA is still being studied [13].

Treatment Strategies

Currently, heart complications of Friedreich ataxia are managed using standard cardiology guidelines, as evidence for medications specifically preventing FA-related heart progression is limited [14]. Treatments are highly individualized:

  • Medications: Depending on your specific symptoms, blood pressure, and whether your pumping function is preserved or reduced, your doctor may prescribe medications like beta-blockers, ACE inhibitors, or diuretics (water pills) [14].
  • Arrhythmia Management: Irregular rhythms may be treated with medications or through electrical cardioversion (a controlled medical procedure to restore a normal heart rhythm) [14].
  • Anticoagulants (Blood Thinners): If you develop atrial fibrillation, your stroke risk increases. Standard risk calculators (like the CHA₂DS₂-VASc score) might underestimate the risk of blood clots in FA, so your cardiologist must carefully balance your stroke risk, bleeding risk, and fall risk when recommending blood thinners [15][16]. Never start or stop a blood thinner without direct medical advice.
  • Advanced Therapies: In rare cases of severe heart failure that no longer responds to medication, advanced options like a heart transplant may be considered by a specialized team [17].

When to Seek Urgent Care

Do not wait for your next routine appointment if you experience sudden or severe symptoms. Seek emergency medical help immediately if you develop:

  • Sudden fainting or near-fainting
  • Severe or new chest pain
  • Severe or rapidly worsening shortness of breath
  • A sustained racing, fluttering, or irregular heartbeat
  • Rapidly increasing swelling in your legs or sudden weight gain

Common questions in this guide

Why does Friedreich ataxia affect the heart?
Friedreich ataxia reduces the supply of frataxin, a protein heart cells need to make energy. This disrupts the cells’ energy systems and iron handling, which can cause a form of heart muscle disease called mitochondrial cardiomyopathy.
What heart problems can Friedreich ataxia cause?
Heart involvement can cause thickened heart walls, difficulty relaxing and filling, irregular heartbeats, and, in some people, heart failure. The pattern and pace vary widely, and some people have few or no noticeable symptoms for years.
Can Friedreich ataxia cause hypertrophic cardiomyopathy?
Yes. The heart muscle, usually the left ventricle, may become thickened in Friedreich ataxia. This thickening is linked to problems in the cells’ energy systems rather than the structural protein mutations that often cause hypertrophic cardiomyopathy in other people, and pumping strength may remain normal early on.
What heart tests are used to monitor Friedreich ataxia?
Cardiologists commonly use an ECG and echocardiogram for routine monitoring, often yearly depending on age, symptoms, and prior results. A Holter monitor, cardiac MRI, or blood tests may be added when symptoms or initial findings suggest that closer evaluation is needed.
How are heart complications from Friedreich ataxia treated?
Treatment is individualized and generally follows standard cardiology care. Depending on heart function and rhythm, it may include beta-blockers, ACE inhibitors, diuretics, rhythm treatment, or blood thinners for selected people with atrial fibrillation; a heart transplant is considered only rarely for severe heart failure that does not respond to medication.
When should someone with Friedreich ataxia seek emergency care for heart symptoms?
Get emergency help for fainting, new or severe chest pain, severe or worsening shortness of breath, a sustained racing or irregular heartbeat, or rapidly increasing leg swelling or weight. These symptoms can signal a serious rhythm problem or worsening heart function and should not wait for a routine visit.
How does Friedreich ataxia affect decisions about blood thinners?
If atrial fibrillation develops, the risk of stroke may increase, and standard risk calculators may not fully reflect clot risk in Friedreich ataxia. A cardiologist must balance stroke risk, bleeding risk, and fall risk before recommending a blood thinner, so do not start or stop one without medical advice.

Get notified when new evidence is published on Friedreich ataxia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    Friedreich ataxia- pathogenesis and implications for therapies.

    Delatycki MB, Bidichandani SI

    Neurobiology of disease 2019; (132()):104606 doi:10.1016/j.nbd.2019.104606.

    PMID: 31494282
  2. 2

    Cardiovascular Research in Friedreich Ataxia: Unmet Needs and Opportunities.

    Payne RM

    JACC. Basic to translational science 2022; (7(12)):1267-1283 doi:10.1016/j.jacbts.2022.04.005.

    PMID: 36644283
  3. 3

    Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia.

    Monda E, Lioncino M, Rubino M, et al.

    Heart failure clinics 2022; (18(1)):31-37 doi:10.1016/j.hfc.2021.07.001.

    PMID: 34776081
  4. 4

    Serial assessment of echocardiographic measures in Friedreich ataxia.

    Lynch DR, Keita M, Gunther K, et al.

    American heart journal plus : cardiology research and practice 2026; (70()):100869 doi:10.1016/j.ahjo.2026.100869.

    PMID: 42733758
  5. 5

    Friedreich's ataxia-associated childhood hypertrophic cardiomyopathy: a national cohort study.

    Norrish G, Rance T, Montanes E, et al.

    Archives of disease in childhood 2022; (107(5)):450-455 doi:10.1136/archdischild-2021-322455.

    PMID: 34610949
  6. 6

    A 22-Year Follow-up Study of Long-term Cardiac Outcome and Predictors of Survival in Friedreich Ataxia.

    Pousset F, Legrand L, Monin ML, et al.

    JAMA neurology 2015; (72(11)):1334-41 doi:10.1001/jamaneurol.2015.1855.

    PMID: 26414159
  7. 7

    Characterizing cardiac phenotype in Friedreich's ataxia: The CARFA study.

    Legrand L, Weinsaft JW, Pousset F, et al.

    Archives of cardiovascular diseases 2022; (115(1)):17-28 doi:10.1016/j.acvd.2021.10.010.

    PMID: 34920960
  8. 8

    Mitochondrial dynamics and repair differences in two mouse models of Friedreich's ataxia.

    Salinas L, Figueroa F, Montgomery-Bowie CB, et al.

    The Journal of physiology 2026; (604(20)):8360-8378 doi:10.1113/JP291356.

    PMID: 42850823
  9. 9

    Mitochondrial pore opening and loss of Ca2+ exchanger NCLX levels occur after frataxin depletion.

    Purroy R, Britti E, Delaspre F, et al.

    Biochimica et biophysica acta. Molecular basis of disease 2018; (1864(2)):618-631 doi:10.1016/j.bbadis.2017.12.005.

    PMID: 29223733
  10. 10

    Heart disease in Friedreich's ataxia.

    Hanson E, Sheldon M, Pacheco B, et al.

    World journal of cardiology 2019; (11(1)):1-12 doi:10.4330/wjc.v11.i1.1.

    PMID: 30705738
  11. 11

    The cardiomyopathy in Friedreich's ataxia - New biomarker for staging cardiac involvement.

    Weidemann F, Liu D, Hu K, et al.

    International journal of cardiology 2015; (194()):50-7.

    PMID: 26005806
  12. 12

    Ectopic Burden via Holter Monitors in Friedreich Ataxia.

    Mejia E, Lynch A, Hearle P, et al.

    Pediatric neurology 2021; (117()):29-33 doi:10.1016/j.pediatrneurol.2021.01.004.

    PMID: 33652339
  13. 13

    Significance of NT-proBNP and High-sensitivity Troponin in Friedreich Ataxia.

    Legrand L, Maupain C, Monin ML, et al.

    Journal of clinical medicine 2020; (9(6)) doi:10.3390/jcm9061630.

    PMID: 32481586
  14. 14

    Management of Friedreich Ataxia-Associated Cardiomyopathy in Pregnancy: A Review of the Literature.

    Peterson AN, Hickerson LC, Pschirrer ER, et al.

    The American journal of cardiology 2024; (210()):118-129 doi:10.1016/j.amjcard.2023.10.019.

    PMID: 37838071
  15. 15

    Left atrial appendage thrombosis in a patient with Friedreich Ataxia-related cardiomyopathy, left ventricular systolic dysfunction, and atrial fibrillation.

    Russo M, Nuzzo A, Foschi M, et al.

    SAGE open medical case reports 2021; (9()):2050313X211056419 doi:10.1177/2050313X211056419.

    PMID: 34733522
  16. 16

    Disease-specific aspects of management of cardiac arrhythmias in patients with muscular dystrophies.

    Majewski J, Varma M, Davis G, Lelakowski J

    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 2019; (47(280)):153-156.

    PMID: 31760399
  17. 17

    Advanced Heart Failure in Friedreich's Ataxia: A Story of Challenges, Opportunities, and Hope.

    Miyashita S, Zaki A, Schlabach K, et al.

    JACC. Case reports 2026; (31(17)):107391 doi:10.1016/j.jaccas.2026.107391.

    PMID: 41860485

This page explains how Friedreich ataxia can affect the heart for informational purposes only and does not replace medical advice. Discuss your monitoring, symptoms, and treatment with your cardiologist and care team.